Neuraxis Inc (NRXS) Stock Price, Quote & News

Company Profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly kno...

Industry: Biotechnology

Sector: Healthcare

Phone: 812 689 0791

Website: neuraxis.com

Address:

11611 North Meridian St, Suite 330, Carmel, United States

Gurss Jun. 26 at 10:37 PM

Buy:- $CHUC $NRXS $CATX $QBTS

0 · Reply

Gurss Jun. 26 at 4:49 PM

$NRXS buy

0 · Reply

UpsideRide Jun. 26 at 2:02 PM

Bought $ENVX $NRXS this morning, lets GO!

0 · Reply

cleverrox Jun. 23 at 6:10 PM

New full depth article on Neuraxis $NRXS https://microcapopportunities.substack.com/p/neuraxis-nrxs-a-steal-at-current

0 · Reply

wallstpirate Jun. 19 at 11:35 AM

$NRXS RE: Adult ib stim: Sergio an SA and Substack analyst asked them about adult ib stim on the Q3 /24 cc which is on this printed transcript link on bottom. And then another question I get to ask is, why isn't it available for adults? And will you be shooting in that direction? Brian Carrico Yes, that's another great question, Sergio. We're going to release a new deck today that will be in our IR firm. And we just haven't gotten to talk about that in our earnings calls yet, but we are well on our way to approaching the FDA for an adult indication expansion that would range from 21 through all adult ages. And I believe that we're aiming for late 2025 to earn that FDA indication. They also say it is a much larger market > 2B etc. Worth the read. https://seekingalpha.com/article/4737932-neuraxis-inc-nrxs-q3-2024-earnings-call-transcript

0 · Reply

wallstpirate Jun. 19 at 11:33 AM

$NRXS From cc: Regarding children's hospitals, many have been ordering for years, but for a variety of reasons, we have not received early insurance policy coverage in those geographic regions. Once insurance policy coverage is written in these areas, the children's hospitals are expected to increase revenue very quickly because the product is already in their system, therefore, not needing the 120 days to get set up. The second part of the seamless treatment for patients, along with policy coverage is the Category I CPT code.

0 · Reply

JcCapital Jun. 18 at 4:20 PM

$NRXS will pop soon..be patient

0 · Reply

wallstpirate Jun. 18 at 12:22 PM

$NRXS Expands Insurance Coverage for IB-Stim Therapy, Enhancing Access for Patients with Abdominal Pain https://www.nasdaq.com/articles/neuraxis-inc-expands-insurance-coverage-ib-stim-therapy-enhancing-access-patients

0 · Reply

Billwinez Jun. 17 at 1:54 PM

$NRXS should be over $6. What is going on?

0 · Reply

Black_Socrates Jun. 17 at 1:12 PM

$NRXS https://finance.yahoo.com/news/neuraxis-announces-medical-policy-coverage-120000674.html

0 · Reply

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives

May 22, 2025, 1:03 PM EDT - 5 weeks ago

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

May 21, 2025, 7:00 AM EDT - 5 weeks ago

NeurAxis Announces $5.0 Million Registered Direct Offering

May 12, 2025, 1:58 PM EDT - 6 weeks ago

NeurAxis, Inc. (NRXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 8:15 AM EDT - 6 weeks ago

NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

May 5, 2025, 9:00 AM EDT - 7 weeks ago

NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025

Mar 20, 2025, 4:18 PM EDT - 3 months ago

NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 8:15 AM EDT - 3 months ago

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues

Mar 12, 2025, 9:00 AM EDT - 3 months ago

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025

Jan 21, 2025, 1:45 PM EST - 5 months ago

UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States

Jan 21, 2025, 9:00 AM EST - 5 months ago

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

Jan 13, 2025, 9:00 AM EST - 5 months ago

NeurAxis Inc. Issues Letter to Shareholders

Jan 6, 2025, 9:00 AM EST - 6 months ago

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Nov 15, 2024, 2:04 PM EST - 7 months ago

NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:10 AM EST - 8 months ago

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

Oct 22, 2024, 9:00 AM EDT - 8 months ago

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

Sep 19, 2024, 9:00 AM EDT - 10 months ago

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

Aug 27, 2024, 9:00 AM EDT - 10 months ago

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024

Aug 13, 2024, 9:00 AM EDT - 11 months ago

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

Aug 11, 2024, 5:44 AM EDT - 11 months ago

NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 8:00 AM EDT - 11 months ago

NeurAxis Reports Second Quarter 2024 Financial Results

Jun 7, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

May 22, 2024, 1:34 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript

May 22, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports First Quarter 2024 Financial Results

May 21, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 15, 2024, 4:30 PM EDT - 1 year ago

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

Apr 23, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New Medical Policy Coverage in North Dakota

Apr 9, 2024, 6:45 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q4 2023 Earnings Call Transcript

Apr 9, 2024, 4:05 PM EDT - 1 year ago

NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Apr 1, 2024, 4:15 PM EDT - 1 year ago

NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024

Mar 27, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry

Mar 11, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces Highmark BCBS Policy Coverage

Mar 4, 2024, 9:00 AM EST - 1 year ago

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

Feb 27, 2024, 11:00 AM EST - 1 year ago

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Jan 31, 2024, 9:00 AM EST - 1 year ago

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Dec 20, 2023, 9:00 AM EST - 1 year ago

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

Nov 20, 2023, 5:30 PM EST - 1 year ago

NeurAxis Reports Third Quarter 2023 Financial Results

Nov 15, 2023, 9:00 AM EST - 1 year ago

NeurAxis Announces CareFirst BCBS Policy Coverage

Nov 14, 2023, 9:00 AM EST - 1 year ago

NeurAxis Secures $3 Million Financing

Nov 8, 2023, 9:00 AM EST - 1 year ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

Sep 21, 2023, 8:00 AM EDT - 1 year ago

NeurAxis Reports Second Quarter 2023 Financial Results

Sep 13, 2023, 9:00 AM EDT - 1 year ago

NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase

Sep 12, 2023, 9:00 AM EDT - 1 year ago

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS

Aug 29, 2023, 9:00 AM EDT - 1 year ago

NeurAxis Highlights Pediatric Post-Concussion Clinical Study

Aug 24, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Strength of its Board of Directors

Aug 22, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome

Aug 17, 2023, 9:02 AM EDT - 2 years ago

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue

Aug 15, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023

Aug 12, 2023, 6:00 AM EDT - 2 years ago

U.S. IPO Weekly Recap: IPO Market Sees Fitness, Liquor Marketing, And Medical Devices

ANL FTEL NWGL VFS

Aug 11, 2023, 9:30 AM EDT - 2 years ago

Goldman Small Cap Research Publishes New Research Report on NeurAxis, Inc.

Gurss Jun. 26 at 10:37 PM

Buy:- $CHUC $NRXS $CATX $QBTS

0 · Reply

Gurss Jun. 26 at 4:49 PM

$NRXS buy

0 · Reply

UpsideRide Jun. 26 at 2:02 PM

Bought $ENVX $NRXS this morning, lets GO!

0 · Reply

cleverrox Jun. 23 at 6:10 PM

New full depth article on Neuraxis $NRXS https://microcapopportunities.substack.com/p/neuraxis-nrxs-a-steal-at-current

0 · Reply

wallstpirate Jun. 19 at 11:35 AM

0 · Reply

wallstpirate Jun. 19 at 11:33 AM

0 · Reply

JcCapital Jun. 18 at 4:20 PM

$NRXS will pop soon..be patient

0 · Reply

wallstpirate Jun. 18 at 12:22 PM

0 · Reply

Billwinez Jun. 17 at 1:54 PM

$NRXS should be over $6. What is going on?

0 · Reply

Black_Socrates Jun. 17 at 1:12 PM

$NRXS https://finance.yahoo.com/news/neuraxis-announces-medical-policy-coverage-120000674.html

0 · Reply

JarvisFlow Jun. 16 at 3:26 PM

Craig-Hallum has adjusted their stance on Neuraxis ( $NRXS ), setting the rating to Buy with a target price of 7.

0 · Reply

Billwinez Jun. 13 at 12:35 PM

$NRXS I see a June 4 filing, votes for directors and more shares. What is going on with this company? Legit or dilution pump and dump? I admit these filings are confusing to me.

1 · Reply

Camelinvesting Jun. 12 at 11:13 PM

$NRXS out for now with loss. Still in my watching list

0 · Reply

RedDogSailor Jun. 12 at 6:23 PM

$NRXS good product, growing revenue and great news. No reason this stock should be so down

0 · Reply

TruthTooPower Jun. 12 at 12:31 PM

$NRXS !!! Does Anyone have an idea of how much more market capitalization our markets would have if the SEC banned Short Sales? The Manipulation of the Market By Shorts destroys a lot of markets… and yes the SEC when it was created they did consider banning Shorts!!

0 · Reply

TruthTooPower Jun. 12 at 12:25 PM

$NRXS !!! Billwinz Shorts Destroy Legit Businesses Also That’s Why I Don’t Bow To Any One Picking on New Traders making them Feel Stupid with their Trading Decisions… Evil is Everywhere they pick on the Vulnerable for their Gain!!!

0 · Reply

Black_Socrates Jun. 11 at 4:07 PM

$NRXS The price target has been adjusted to $5.5. It used to $4.75 till yesterday. Someone must be hoarding silently.

0 · Reply

Billwinez Jun. 11 at 11:29 AM

$NRXS why is it going down? The company looks legit.

0 · Reply

Panama73 Jun. 10 at 7:56 PM

$CARM $NRXS Low float had news this morning.

0 · Reply

Panama73 Jun. 10 at 7:42 PM

$CARM $NRXS

0 · Reply

_www_larval_com_ Jun. 10 at 1:42 PM

$KLTO 15%[88%] $OMH -14%[-43%] $MSW 8%[2%] $CMTL -7%[-26%] $NRXS -7%[2%] most notable movement within the first minutes of trading.

0 · Reply

Camelinvesting Jun. 10 at 12:57 PM

$NRXS This will cross 3$ definitely. 💯 Let’s see if touches 4$. Great & promising news

1 · Reply

Market Cap	18.62M
Revenue (ttm)	2.69M
Net Income (ttm)	-8.24M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-306.32%
Debt to Equity Ratio	0.00

Volume	86,100
Avg Vol	2,014,076
Day's Range	N/A - N/A
Shares Out	7.22M
Stochastic %K	63%
Beta	3.34
Analysts	Strong Sell
Price Target	$7.00